FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.
|Slideshows|March 16, 2020
Will synthetic CBD have a place in dietary supplements?
Author(s)Robby Gardner
What is synthetic CBD? And how might it affect the market for natural, plant-derived CBD?
Advertisement
Advertisement
Related to this article
DolCas Biotech is featuring the turmeric-derived ingredient Curcugen in Mānukora’s Mānuka honey and Numin’s cognitive-support drink.
Formulators are moving toward botanicals like ashwagandha, bacopa, saffron, and PEA that target the stress, cortisol, and nervous-system pathways behind restless nights.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
What the Interim Compounding Pathway for Peptides Could Mean for Supplement Brands
2
What Japan's Red Yeast Rice Crisis Teaches Ingredient Suppliers About FDA's New NDI Guidance
3
Vitaquest's 2027 Consumer Trends Forecast
4
SupplySide Global Panelists Outline Product Opportunities Tied to GLP-1 Medication Use
5